Page last updated: 2024-08-21

alpha-aminopyridine and pulmicort

alpha-aminopyridine has been researched along with pulmicort in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Bethke, TD; Giessmann, T; Hauns, B; Hermann, R; Lahu, G; Reutter, F; Siegmund, W; Weinbrenner, A; Westphal, K; Zech, K1
Erb, KJ; Göggel, R; Werner-Klein, M; Westhof, A1
Bahra, P; Banner, KH; Dale, N; Freeman, MS; Hardaker, EL; Poll, C; Raza, F1
Calverley, P; Celli, BR; Chambers, M; Clark, JF; Hawkins, N; Scott, DA; Thompson, JC; Woods, B1
Aguiar, JA; Ask, K; Cao, Q; Doxey, AC; Hirota, JA; Hou, V; Huff, RD; Inman, MD; Kim, Y; Miller, MS; Revill, S; Tiessen, N1
Bischoff, A; Dunstan, TA; Fettis, MM; Hayes, ME; Hernandez, A; Hobson, AD; Jia, Y; Marvin, CC; McPherson, M; Oh, JZ; Tian, Y; Vargo, TR; Wang, L1

Reviews

2 review(s) available for alpha-aminopyridine and pulmicort

ArticleYear
Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis.
    BMC pulmonary medicine, 2015, Nov-11, Volume: 15

    Topics: Albuterol; Aminopyridines; Beclomethasone; Benzamides; Benzyl Alcohols; Bronchodilator Agents; Budesonide; Chlorobenzenes; Cyclopropanes; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Glucocorticoids; Humans; Indans; Ipratropium; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Quinolones; Survival Rate; Theophylline; Tiotropium Bromide; Triamcinolone

2015
Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire international, 2016, Volume: 25, Issue:176

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aminopyridines; Benzamides; Bronchodilator Agents; Budesonide; Cyclopropanes; Fluticasone; Formoterol Fumarate; Humans; Ipratropium; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Recurrence; Salmeterol Xinafoate; Theophylline; Tiotropium Bromide

2016

Trials

1 trial(s) available for alpha-aminopyridine and pulmicort

ArticleYear
The oral, once-daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonide.
    Journal of clinical pharmacology, 2007, Volume: 47, Issue:8

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Inhalation; Adult; Aminopyridines; Anti-Inflammatory Agents; Area Under Curve; Benzamides; Budesonide; Cross-Over Studies; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Drug Interactions; Humans; Male

2007

Other Studies

4 other study(ies) available for alpha-aminopyridine and pulmicort

ArticleYear
Development and characterisation of a novel and rapid lung eosinophil influx model in the rat.
    Pulmonary pharmacology & therapeutics, 2008, Volume: 21, Issue:4

    Topics: Alum Compounds; Aminopyridines; Animals; Anti-Inflammatory Agents; Asthma; Benzamides; Bronchoalveolar Lavage Fluid; Budesonide; Cyclopropanes; Dibenzazepines; Disease Models, Animal; Eosinophils; Histamine H1 Antagonists; Imidazoles; Ketotifen; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphodiesterase Inhibitors; Prednisolone; Rats; Rats, Inbred BN

2008
Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.
    British journal of pharmacology, 2010, Volume: 160, Issue:8

    Topics: Adrenal Cortex Hormones; Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Bronchoalveolar Lavage Fluid; Budesonide; Cyclopropanes; Disease Models, Animal; Inflammation Mediators; Lipopolysaccharides; Lung; Male; Mucus; Neutrophil Infiltration; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pneumonia; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Time Factors; Tobacco Smoke Pollution

2010
Potentiation of long-acting β
    Respiratory research, 2021, Oct-19, Volume: 22, Issue:1

    Topics: Adrenergic beta-2 Receptor Agonists; Aminopyridines; Benzamides; Benzothiazoles; Budesonide; Cell Line; Chemokines; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Drug Synergism; Drug Therapy, Combination; Epithelial Cells; Formoterol Fumarate; Glucocorticoids; Humans; Lung; Multidrug Resistance-Associated Proteins; Nitriles; Phosphodiesterase 4 Inhibitors; Rolipram; Second Messenger Systems; Triazoles

2021
Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody-Drug Conjugates.
    Bioconjugate chemistry, 2023, 10-18, Volume: 34, Issue:10

    Topics: Animals; Budesonide; Carbamates; Immunoconjugates; Mice

2023